Home > Boards > US Listed > Biotechs > Cassava Sciences Inc (SAVA)

PTIE awesome presentation out! http://investor.paintrials.com/static-files/2830ee11-15b5-4ccc

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
~ Blue ~ Member Profile
Member Level 
Followed By 2,067
Posts 101,479
Boards Moderated 2
Alias Born 08/25/10
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2019 4:42:36 PM
Cassava Sciences Announces Additional Positive Phase 2a Clinical Data in Alzheimer’s Disease at CTAD 2019 GlobeNewswire Inc. - 12/5/2019 9:00:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/29/2019 8:45:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2019 8:30:48 AM
Cassava Sciences Announces Recent Clinical Highlights and Third Quarter 2019 Financial Results GlobeNewswire Inc. - 10/29/2019 8:15:05 AM
Cassava Sciences’ Clinical Results in Alzheimer’s Selected as Late-Breaking News at CTAD 2019 GlobeNewswire Inc. - 10/24/2019 8:30:05 AM
Cassava Sciences Initiates Phase 2b Clinical Study in Alzheimer’s Patients GlobeNewswire Inc. - 9/16/2019 8:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/13/2019 12:30:09 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/13/2019 8:41:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 7:45:57 AM
Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients GlobeNewswire Inc. - 9/9/2019 7:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/5/2019 5:31:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/4/2019 5:04:40 PM
Cassava Sciences to Present at H.C. Wainwright’s 21st Annual Global Investment Conference GlobeNewswire Inc. - 9/3/2019 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/12/2019 4:08:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2019 3:06:06 PM
Cassava Sciences Announces Second Quarter 2019 Financial Results GlobeNewswire Inc. - 8/12/2019 8:30:00 AM
Cassava Sciences to Present at Maxim Group’s Conference on Alzheimer’s Disease GlobeNewswire Inc. - 6/18/2019 8:30:00 AM
Cassava Sciences Announces New Website Launch GlobeNewswire Inc. - 5/28/2019 8:29:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/15/2019 5:52:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 4:31:52 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/2/2019 4:59:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2019 8:46:39 AM
Cassava Sciences Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 4/29/2019 8:30:00 AM
Cassava Sciences Completes Patient Enrollment for a Phase 2a Study in Patients with Alzheimer’s Disease GlobeNewswire Inc. - 4/15/2019 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist